Dr Madeline Dans
Honorary (Fellow)
Department of Medical Biology (WEHI)
27 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
MK-7602: a potent multi-stage dual-targeting antimalarial
DOI: 10.1016/j.ebiom.2025.1060612026
Journal article
Exploration and Characterization of the Antimalarial Activity of Pyrimidine-2,4-Diamines for which Resistance is Mediated by the ABCI3 Transporter
DOI: 10.1002/cmdc.2025007392025
Journal article
Deconvolution of the On-Target Activity of Plasmepsin V Peptidomimetics in Plasmodium falciparum Parasites
DOI: 10.1021/acsinfecdis.5c007422025
Journal article
Optimization and Characterization of the Antimalarial Activity of N-Aryl Acetamides that are Susceptible to Mutations in ROM8 and CSC1
DOI: 10.1021/acs.jmedchem.5c014712025
Journal article
Optimization and Characterization of N-Acetamide Indoles as Antimalarials That Target PfATP4
DOI: 10.1021/acs.jmedchem.5c006142024
Journal article
Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
DOI: 10.1002/cmdc.2024005492024
Journal article
Exploration and characterization of the antimalarial activity of cyclopropyl carboxamides that target the mitochondrial protein, cytochrome b
DOI: 10.1016/j.ejmech.2024.116921
RECENT SCHOLARLY WORKS
2024
Journal article
Author Correction: Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1 (Nature Communications, (2024), 15, 1, (5219), 10.1038/s41467-024-49491-8)
DOI: 10.1038/s41467-024-52849-72024
Journal article
Aryl amino acetamides prevent Plasmodium falciparum ring development via targeting the lipid-transfer protein PfSTART1
DOI: 10.1038/s41467-024-49491-82024
Journal article
Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4
DOI: 10.1021/acs.jmedchem.4c01241